Abstract: Software testing is an essential yet costly phase of the software development lifecycle. While machine learning-based test suite optimization techniques have shown promise in reducing ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Recursion Pharmaceuticals developed a promising artificial intelligence (AI) platform for drug discovery and development. The company's clinical-stage pipeline is just the tip of the iceberg of its ...

According to @gdb, benchmarking multiple AI models by having them play Werewolf would test recursive psychology and theory-of-mind reasoning across agents, including ...

Cierra was an associate writer for CNET's broadband team, covering all things home internet. She is a graduate of the University of North Carolina at Wilmington with a master's degree. Cierra is ...